Marketplace · Netherlands
Pharmacies businesses in Groningen typically transact at 5.2x–7.8x EV/EBITDA, with a sector median of 6.4x in the Netherlands. Northern Netherlands university and energy-transition hub.
Groningen (population ~235,000, Groningen Province) anchors pharmacies transactions at a 6.4x EV/EBITDA median, with most defensible deals landing between 5.2x (conservative) and 7.8x (strong recurring revenue). Northern Netherlands university and energy-transition hub. SMEs in hydrogen and renewable-energy supply, healthcare, IT-services and regional B2B; deal flow growing post-gas-extraction wind-down.
Upswitch is anonymity-by-design — new pharmacies dossiers in Groningen surface here as soon as they pass advisor validation. Subscribe to the alert and we'll notify you within hours of the next listing going live.
Browse all listingsFor a pharmacies SME in Groningen with normalised EBITDA above €200k, expect the headline price to anchor on a 6.4x EV/EBITDA multiple, with a working-capital peg, 5–15% escrow, and (in 35–45% of deals) an earn-out tied to year-one EBITDA or customer retention. Cross-border buyer interest from Belgian acquirers is consistently elevated.
Northern Netherlands university and energy-transition hub. SMEs in hydrogen and renewable-energy supply, healthcare, IT-services and regional B2B; deal flow growing post-gas-extraction wind-down. For pharmacies specifically, Groningen's buyer pool typically includes regional family businesses, Benelux-wide strategic acquirers, and (for deals above ~€2m EV) PE-backed roll-up platforms.